Home
Movement
Investments
Education
Blog
Plans
GeneDx Holdings Corp header image

GeneDx Holdings Corp

WGS

Equity

ISIN null / Valor 126808031

NASDAQ (2026-03-25)
USD 66.95-2.50%

GeneDx Holdings Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

GeneDx Holdings Corp. (Nasdaq: WGS) is a company specializing in genomic insights to enhance health outcomes. The firm focuses on providing advanced genetic testing and diagnostic services, leveraging cutting-edge technology to offer precise and actionable genomic data. GeneDx's offerings are designed to support healthcare providers in diagnosing and managing a wide range of genetic disorders, thereby improving patient care and treatment strategies. The company is publicly traded and regularly reports its financial performance, with its latest results for the first quarter of 2024 scheduled for release after market close on April 29, 2024.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-33.4%1Y
524%3Y
%5Y

Performance

97.2%1Y
110%3Y
109%5Y

Volatility

Market cap

1961 M

Market cap (USD)

Daily traded volume (Shares)

444,107

Daily traded volume (Shares)

1 day high/low

77.8 / 73.985

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Henry Schein Inc
Henry Schein Inc Henry Schein Inc Valor: 83527
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.31%USD 74.25
NovoCure Limited
NovoCure Limited NovoCure Limited Valor: 29570025
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%USD 11.61
Roivant Sciences Limited
Roivant Sciences Limited Roivant Sciences Limited Valor: 113331044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%USD 27.36
Integra Lifesciences Holdings Corp
Integra Lifesciences Holdings Corp Integra Lifesciences Holdings Corp Valor: 912247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%USD 9.55
ICU Medical Inc
ICU Medical Inc ICU Medical Inc Valor: 940704
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.53%USD 131.38
CRISPR Therapeutics Ltd
CRISPR Therapeutics Ltd CRISPR Therapeutics Ltd Valor: 33408113
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.42%USD 47.09
Merit Medical Systems Inc
Merit Medical Systems Inc Merit Medical Systems Inc Valor: 951136
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.83%USD 68.11
Lantheus Holdings Inc
Lantheus Holdings Inc Lantheus Holdings Inc Valor: 24784644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.87%USD 75.63
Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc Valor: 32193461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.00%USD 60.77
AMEDISYS Inc
AMEDISYS Inc AMEDISYS Inc Valor: 399513
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 100.99
SIXFactSetClearbitLogos provided by Clearbit